Ustekinumab for pyoderma gangrenosum.
Nicolas
N
Kluger
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D053759:Interleukin-23 / Q000096:biosynthesis*; D058990:Molecular Targeted Therapy; D017511:Pyoderma Gangrenosum / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D053759:Interleukin-23